IVI RMA North America Rebrands U.S. Operations as Everleap Fertility

Reproductive Medicine Pioneer and Leader in Fertility Research Unites 85+ Clinics and Labs, 200 Physicians and Embryologists Across Nine Brands to Guide Next Generation of Personalized Care and Innovation

BASKING RIDGE, N.J.--(BUSINESS WIRE)--IVI RMA North America, a leader in fertility care and reproductive medicine, announced today that it has rebranded its U.S. operations as Everleap Fertility. Built on the legacy of RMA, Boston IVF, Conceptions and other renowned U.S. fertility practices, Everleap Fertility unites more than 200 physicians and embryologists across more than 85 clinics and IVF laboratories. For over 40 years these professionals have been a driving force in shaping the field of reproductive medicine and have helped hundreds of thousands of patients build families and preserve their fertility.

“We've built something remarkable across nine brands in the United States — each with deep roots in their communities, extraordinary clinical talent, and a shared commitment to patients,” said Lynn Mason, CEO of Everleap Fertility. “We have also experienced massive change in the science of fertility and how we deliver care, making this the right time to unite under one name that signals our collective focus on the next leap forward in reproductive medicine through ever-advancing standards across our clinics, ever-more personalized treatment delivered by expert local teams, and ever-better experiences for every person who comes to us for care.”

Examples of Everleap Fertility’s progress and prominent role in U.S. fertility include:

• A major initiative with Costco and Sesame that helps lower the cost of fertility medication and creates a more accessible pathway to treatment
• Partnering with TMRW to set new standards in tissue storage and bringing the first fully automated embryology lab from Conceivable Life Sciences to the U.S. in 2027
• Offering patients predictable pricing through partnerships with Gaia and PatientFi
• Partnerships with leading academic institutions including the University of North Carolina, Jefferson University, Harvard University and the University of Utah

Revolutionizing Patient Care with Artemis and AiVA

Everleap’s latest milestone along with the rebrand is the unveiling of AiVA, an AI-powered companion to Artemis, the company’s proprietary electronic medical records (EMR), workflow, and clinical intelligence platform. Built on four decades of pioneering reproductive medicine expertise and longitudinal patient and clinical data, AiVA enables physicians to access insights from a comprehensive knowledge base, supporting evidence-based, personalized care and more informed clinical decision-making.

“Everleap and our parent organization, IVI Institute, are well known for advancing the science of fertility with the latest technology,” said Dr. Thomas Molinaro, Chief Medical Officer of Everleap Fertility. “Artemis and AiVA help ensure that our patients throughout the United States benefit from this knowledge as they continue their family-building journeys.”

A Pivotal Time for Fertility Care in the U.S.

In concert with the launch of the new brand, Everleap Fertility is presenting insights from the inaugural IVI Institute Fertility Barometer, adding new data to the national conversation about fertility and reproductive care at a time when 1 in 5 U.S. women of reproductive age have experienced infertility. To learn more about the Fertility Barometer’s findings, visit https://fertilitybarometer.iviinstitute.com/.

About Everleap Fertility

Built on the legacy of RMA, Boston IVF, Conceptions and six other renowned North American fertility practices, Everleap Fertility brings together more than 200 physicians and embryologists across more than 65 clinics and 26 IVF laboratories. Together, we have helped hundreds of thousands of patients build families and have helped shape reproductive medicine for more than 40 years. Everleap Fertility’s national scale and collective intelligence are focused on the next leap forward in reproductive medicine through ever-advancing standards across our clinics, ever-more personalized treatment delivered by expert local teams, and ever-better experiences for every person who comes to us for care. As a member of IVI Institute, the global leader in reproductive medicine, we draw on the unmatched knowledge of our global network to help people through every scenario and ensure patients benefit immediately from advances in our field. For more information, visit www.everleapfertility.com.